H-8060

   Amend House File 555, as passed by the House, as follows:
   1.  Page 1, by striking lines 11 and 12.
   2.  Page 1, line 20, by striking <2023> and inserting <2024>
   3.  Page 1, line 31, by striking <2023> and inserting <2024>
   4.  Page 1, line 34, after <drug> by inserting <, biological product, or device>
   5.  Page 1, line 35, before <with> by inserting <or device>
   6.  Page 2, line 1, after <drug> by inserting <, biological product, or device>
   7.  Page 2, line 3, by striking <2023> and inserting <2024>
   8.  Page 3, line 20, by striking <2023> and inserting <2024>
   9.  Page 4, line 7, by striking <2023> and inserting 2024>
   10.  Page 4, by striking lines 21 through 29.
   11.  Page 4, line 30, by striking <2023> and inserting <2024>
   12.  Page 5, line 4, by striking <2023> and inserting <2024>
   13.  Page 5, line 9, by striking <2023> and inserting <2024>
   14.  Page 5, line 10, by striking <2023> and inserting <2024>
   15.  Page 5, by striking lines 12 through 17.
   16.  Page 5, line 18, by striking <2023> and inserting <2024>
   17.  Page 6, line 3, by striking <2023> and inserting <2024>
   18.  Page 6, line 11, by striking <2023> and inserting <2024>
   19.  Page 6, line 29, by striking <2023> and inserting <2024>
   20.  Page 7, line 8, by striking <2023> and inserting <2024>
   21.  Page 7, line 18, by striking <2023> and inserting <2024>
   22.  Page 7, line 25, by striking <2023> and inserting <2024>
   23.  Page 7, line 31, by striking <2023> and inserting <2024>
   24.  Page 8, line 17, by striking <2023> and inserting <2024>
   25.  Page 8, line 30, by striking <2023> and inserting <2024>
   26.  Page 9, line 5, by striking <2023> and inserting <2024>
   27.  Page 9, line 27, by striking <2023> and inserting <2024>
   28.  Page 10, line 2, after <board.> by inserting <The board shall not develop or approve a statewide protocol permitting a pharmacist to order and administer any drug intended to induce an abortion as defined in section 146.l.>
   29.  By striking page 10, line 3, through page 11, line 31, and inserting: 
   <Sec. ___.  Section 155A.46, subsection 1, Code 2024, is amended to read as follows:
   1.  A pharmacist may, pursuant to statewide protocols developed and approved by the board in consultation with the department of health and human services and consistent with subsection 2, order and administer an immunization or vaccination. Each protocol, as established by rule, may define the immunization or vaccination allowed to be ordered and administered, any training or qualification required to implement the protocol, and any additional requirements deemed appropriate by the board.
   a.  A pharmacist may, pursuant to statewide protocols developed by the board in consultation with the department of health and human services and consistent with subsection 2, order and administer the following to patients ages eighteen years and older:
   (1)  Opioid antagonists for overdose reversals.
   (2)  Nicotine replacement tobacco cessation products.
   (3)  (1)  An immunization or vaccination recommended by the United States centers for disease control and prevention advisory committee on immunization practices in its approved vaccination schedule for adults.
   (4)  (2)  An immunization or vaccination recommended by the United States centers for disease control and prevention for international travel.
   (5)  (3)  A Tdap (tetanus, diphtheria, acellular pertussis) vaccination in a booster application.
   (6)  (4)  Other emergency immunizations or vaccinations in response to a public health emergency.
   (7)  (5)  An immunization or vaccination for COVID-19 as defined in section 686D.2.
   b.  A pharmacist may, pursuant to statewide protocols developed by the board in consultation with the department of health and human services and consistent with subsection 2, order and administer the following to patients ages six months and older:
   (1)  A vaccine An immunization or immunization vaccination for influenza.
   (2)  Other emergency immunizations or vaccines in response to a public health emergency.
   c.  A pharmacist may, pursuant to statewide protocols developed by the board in consultation with the department of health and human services and consistent with subsection 2, order and administer the final two doses in a course of vaccinations for HPV to patients ages eleven years and older.
   d.  Prior to the ordering and administration of a vaccination an immunization or immunization vaccination authorized by this subsection, pursuant to statewide protocols, a licensed pharmacist shall consult and review the statewide immunization registry or health information network. The board shall adopt rules requiring the reporting of the administration of vaccines and immunizations and vaccinations authorized by this subsection to a patient’s primary health care provider, primary physician, and a statewide immunization registry or health information network.
   e.  A pharmacist may, pursuant to statewide protocols developed by the board in consultation with the department of health and human services and consistent with subsection 2, order and administer the following to patients ages six years and older:
   (1)  Point-of-care testing and treatment for influenza, streptococcus A, and COVID-19 as defined in section 686D.2 at the point of interaction between a pharmacist and a patient.
   (2)  Point-of-care testing at the point of interaction between a pharmacist and a patient in response to a public health emergency.>
   30.  Page 11, line 32, by striking <2023> and inserting <2024>
   31.  Page 12, line 4, by striking <2023> and inserting <2024>
   32.  Page 12, after line 10 by inserting: 
   <Sec. ___.  Section 514F.7, subsection 4, paragraph a, Code 2024, is amended to read as follows:
   a.  Prevent a health carrier, health benefit plan, or utilization review organization from requiring a covered person to try a prescription drug with the same generic name and demonstrated bioavailability or a biological product that is an interchangeable biological product pursuant to section 155A.32 

as defined in section 155A.3 prior to providing coverage for the equivalent branded prescription drug.>
   33.  Page 12, line 11, after <155A.6B,> by inserting <155A.11,>
   34.  Page 12, line 12, by striking <2023> and inserting <2024>
   35.  By renumbering, redesignating, and correcting internal references as necessary.